Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance
MENLO PARK, CA--(Marketwired - Mar 6, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) 2016 revenue of $81.3 million, a 62 percent increase from 2015 Fourth quarter 2016 revenue of $23.8 million, a 59 percent increase from fourth quarter 2015 2016 …